Washington Trust Advisors’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$444 Sell
19
-42
-69% -$1.31K ﹤0.01% 678
2025
Q4
$2.68K Buy
+61
New +$3.42K ﹤0.01% 568
2024
Q4
Sell
-149
Closed -$7.3K 660
2024
Q3
$6.49K Hold
149
﹤0.01% 541
2024
Q2
$4.17K Sell
149
-90
-38% -$2.37K ﹤0.01% 584
2024
Q1
$6.42K Sell
239
-139
-37% -$3.96K ﹤0.01% 538
2023
Q4
$10.6K Buy
378
+105
+38% +$2.48K ﹤0.01% 463
2023
Q3
$5.78K Buy
273
+14
+5% +$382 ﹤0.01% 530
2023
Q2
$8.8K Sell
259
-417
-62% -$13.9K ﹤0.01% 478
2023
Q1
$21.9K Buy
676
+172
+34% +$5.71K ﹤0.01% 408
2022
Q4
$16.9K Sell
504
-630
-56% -$19.2K ﹤0.01% 442
2022
Q3
$34K Buy
1,134
+172
+18% +$6.3K ﹤0.01% 443
2022
Q2
$33K Buy
962
+428
+80% +$16.9K ﹤0.01% 459
2022
Q1
$28K Buy
+534
New +$26.9K ﹤0.01% 538

Other funds holding DOCS

Washington Trust Advisors's DOCS Position: Q1 2026 in Review

Washington Trust Advisors reduced its Doximity (DOCS) stake by 69% in Q1 2026, selling an estimated $1.31K and leaving 19 shares worth $444. The position accounts for ﹤0.01% of the portfolio, ranked #678.

Washington Trust Advisors first reported a position in DOCS in Q1 2022 and has held it in 13 quarters since. The position peaked at $34K in Q3 2022. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • Washington Trust Advisors held 19 shares of Doximity worth $444 as of Q1 2026.
  • Washington Trust Advisors sold 42 Doximity shares in Q1 2026, an estimated $1.31K.
  • Doximity made up ﹤0.01% of Washington Trust Advisors's portfolio in Q1 2026, its #678 holding.
  • Washington Trust Advisors first reported a position in Doximity in Q1 2022 and has held it in 13 quarters since.
  • Washington Trust Advisors's Doximity position peaked at $34K in Q3 2022.
  • 419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on Washington Trust Advisors's 13F filing for Q1 2026, filed 6 Apr 2026.